
Spironolactone may block the action of mitotane. Avoid concomitant use of mitotane with spironolactone.
Mitotane is a strong CYP3A inducer. Concomitant use of Mitotane may decrease the levels of CYP3A substrates, which may reduce the activity of these substrates.
Avoid concomitant use of Mitotane with other CYP3A substrates, where minimal level changes may lead to serious therapeutic failures. If concomitant use cannot be avoided, modify the dosage of the CYP3A substrate in accordance with the approved product labeling.
Avoid concomitant use of Mitotane with hormonal contraceptives.
Mitotane may induce the metabolism of warfarin, which may reduce its level and its efficacy.
Avoid concomitant use of Mitotane with warfarin. If concomitant use cannot be avoided, monitor INR more frequently and adjust warfarin dose as recommended in accordance with the recommendations in the warfarin Prescribing Information.
from FDA,2024.01
Mitotane is of particular concern for the risks of concomitant use with other drugs in the treatment of specific endocrine disorders.Which drugs interact with mitotaneSome sedative···【more】
Article source:Lucius LaosRelease date:2025-05-12Recommended:95
Understanding drug interactions is an important reference for clinical use.What are the drug interactions ofWhen the drug is used in combination, it is necessary to pay attention t···【more】
Article source:Lucius LaosRelease date:2025-05-12Recommended:88
The therapeutic effect of Mitotane is aimed at adrenal cortical carcinoma, hyperplasia, and tumor-induced cortisolism without surgical options, and is characterized by fine regulat···【more】
Article source:Lucius LaosRelease date:2024-08-20Recommended:170
Designed for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, Mitotane is distinguished by its precise regulation and inhibition of adrenal c···【more】
Article source:Lucius LaosRelease date:2024-08-20Recommended:177
Mitotane was developed to address inoperable adrenal cortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is the careful regulation and inhib···【more】
Article source:Lucius LaosRelease date:2024-08-20Recommended:173

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: